Sol-Gel Technologies (SLGL) Return on Sales Growth (1y) (2019 - 2026)
Sol-Gel Technologies (SLGL) Return on Sales Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | - |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - | - |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 0.00 |
| 10 | Sol-Gel Technologies | 237.56 Mn | 227.43 Mn | - | 27.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.00 |
| Dec 31, 2025 | 112.00 |
| Sep 30, 2025 | -16.00 |
| Jun 30, 2025 | 0.00 |
| Dec 31, 2024 | -82.00 |
| Sep 30, 2024 | 29.00 |
| Jun 30, 2024 | 11.00 |
| Dec 31, 2023 | 390.00 |
| Sep 30, 2023 | -16.00 |
| Jun 30, 2023 | -11.00 |
| Dec 31, 2022 | -510.00 |
| Sep 30, 2022 | -15.00 |
| Jun 30, 2022 | -9.00 |
| Mar 31, 2022 | -6.00 |
| Dec 31, 2021 | 4.00 |
| Sep 30, 2021 | 5.00 |
| Jun 30, 2021 | 2.00 |
| Mar 31, 2021 | 4.00 |
| Dec 31, 2020 | 8.00 |
| Sep 30, 2020 | -6.00 |